Legal & General Group
ACOR

Legal & General Group’s Acorda Therapeutics ACOR Stock Holding History

Legal & General Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,060
Closed -$119K – 3493
2020
Q1 		$119K Buy
1,060
+51
+5% +$10K ﹤0.01% 2365
2019
Q4 		$265K Buy
1,009
+44
+5% +$11.1K ﹤0.01% 2336
2019
Q3 		$332K Buy
965
+96
+11% +$52.2K ﹤0.01% 2247
2019
Q2 		$800K Hold
869
– – ﹤0.01% 2020
2019
Q1 		$1.39M Buy
869
+75
+9% +$135K ﹤0.01% 1851
2018
Q4 		$1.47M Buy
794
+4
+0.5% +$8.7K ﹤0.01% 1729
2018
Q3 		$1.87M Sell
790
-65
-8% -$201K ﹤0.01% 1727
2018
Q2 		$2.91M Buy
855
+48
+6% +$147K ﹤0.01% 1463
2018
Q1 		$2.29M Buy
807
+22
+3% +$65.9K ﹤0.01% 1548
2017
Q4 		$2.02M Buy
785
+37
+5% +$105K ﹤0.01% 1617
2017
Q3 		$2.12M Buy
748
+8
+1% +$21.1K ﹤0.01% 1553
2017
Q2 		$1.75M Buy
740
+64
+9% +$127K ﹤0.01% 1601
2017
Q1 		$1.73M Buy
676
+9
+1% +$25.9K ﹤0.01% 1557
2016
Q4 		$1.5M Buy
667
+305
+84% +$725K ﹤0.01% 1569
2016
Q3 		$907K Buy
362
+267
+281% +$797K ﹤0.01% 1435
2016
Q2 		$289K Hold
95
– – ﹤0.01% 1627
2016
Q1 		$304K Buy
95
+20
+27% +$83K ﹤0.01% 1578
2015
Q4 		$386K Hold
75
– – ﹤0.01% 1408
2015
Q3 		$239K Buy
75
+7
+10% +$27.1K ﹤0.01% 1623
2015
Q2 		$278K Hold
68
– – ﹤0.01% 1574
2015
Q1 		$276K Buy
68
+17
+33% +$77.9K ﹤0.01% 1540
2014
Q4 		$254K Hold
51
– – ﹤0.01% 1463
2014
Q3 		$212K Buy
+51
New +$191K ﹤0.01% 1481

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legal & General Group's ACOR Position: Q2 2020 in Review

Legal & General Group sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 1,060 shares — an estimated $119K sold.

Legal & General Group first reported a position in ACOR in Q3 2014 and held it in 23 quarters. The position peaked at $2.91M in Q2 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Legal & General Group reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Legal & General Group sold 1,060 Acorda Therapeutics shares in Q2 2020, an estimated $119K.
  • Legal & General Group first reported a position in Acorda Therapeutics in Q3 2014 and held it in 23 quarters.
  • Legal & General Group's Acorda Therapeutics position peaked at $2.91M in Q2 2018.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.